JP2024535124A5 - - Google Patents

Info

Publication number
JP2024535124A5
JP2024535124A5 JP2024538780A JP2024538780A JP2024535124A5 JP 2024535124 A5 JP2024535124 A5 JP 2024535124A5 JP 2024538780 A JP2024538780 A JP 2024538780A JP 2024538780 A JP2024538780 A JP 2024538780A JP 2024535124 A5 JP2024535124 A5 JP 2024535124A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
binding fragment
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538780A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535124A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/074735 external-priority patent/WO2023036774A1/en
Publication of JP2024535124A publication Critical patent/JP2024535124A/ja
Publication of JP2024535124A5 publication Critical patent/JP2024535124A5/ja
Pending legal-status Critical Current

Links

JP2024538780A 2021-09-07 2022-09-06 破傷風毒素に結合する抗体およびその使用 Pending JP2024535124A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2021/074596 2021-09-07
EP2021074596 2021-09-07
PCT/EP2022/074735 WO2023036774A1 (en) 2021-09-07 2022-09-06 Antibodies binding to tetanus toxin and uses thereof

Publications (2)

Publication Number Publication Date
JP2024535124A JP2024535124A (ja) 2024-09-26
JP2024535124A5 true JP2024535124A5 (cg-RX-API-DMAC7.html) 2025-09-17

Family

ID=77864578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538780A Pending JP2024535124A (ja) 2021-09-07 2022-09-06 破傷風毒素に結合する抗体およびその使用

Country Status (5)

Country Link
US (1) US20250129142A1 (cg-RX-API-DMAC7.html)
EP (1) EP4399226A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024535124A (cg-RX-API-DMAC7.html)
CN (1) CN118139879A (cg-RX-API-DMAC7.html)
WO (1) WO2023036774A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122103330A (zh) * 2024-11-19 2026-05-29 北京科兴中维生物技术有限公司 抗破伤风毒素中和抗体及应用
CN120829503B (zh) * 2025-09-18 2025-12-26 北京科兴中维生物技术有限公司 抗破伤风毒素抗体及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076677A2 (en) 2003-02-26 2004-09-10 Institute For Research In Biomedicine Monoclonal antibody production by ebv transformation of b cells
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
CN1305904C (zh) * 2003-12-30 2007-03-21 龚小迪 人源的抗破伤风毒素单克隆抗体的制备和应用
MX2009012343A (es) 2007-05-14 2010-02-10 Biogen Idec Inc Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello.
ES2525346T3 (es) 2008-10-22 2014-12-22 Institute For Research In Biomedicine Métodos para producir anticuerpos a partir de células plasmáticas
US8326547B2 (en) 2009-10-07 2012-12-04 Nanjingjinsirui Science & Technology Biology Corp. Method of sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm
JP7368670B2 (ja) * 2017-12-29 2023-10-25 チューハイ トリノマブ ファーマシューティカル カンパニー,リミティド 破傷風毒素に対する完全天然型ヒト中和モノクロナル抗体及びその応用

Similar Documents

Publication Publication Date Title
JP7811143B2 (ja) 黄色ブドウ球菌(staphylococcus aureus)感染症を治療および予防するための組成物および方法
US20200347130A1 (en) CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof
EP4353744A1 (en) Antibody against respiratory syncytial virus and use thereof
JP2022512647A5 (cg-RX-API-DMAC7.html)
US20220324949A1 (en) Anti-alpha-hemolysin antibody and use thereof
JP2022512646A5 (cg-RX-API-DMAC7.html)
US20250059266A1 (en) Antibodies for treating alpha-synucleinopathies
JP2023182689A5 (cg-RX-API-DMAC7.html)
CN113416249B (zh) 针对破伤风毒素的组合物
JPWO2022044573A5 (cg-RX-API-DMAC7.html)
JP2021155416A5 (cg-RX-API-DMAC7.html)
JP2022531552A5 (cg-RX-API-DMAC7.html)
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF
JP2021525512A5 (cg-RX-API-DMAC7.html)
US20040198960A1 (en) Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae
US20240010711A1 (en) Compositions and methods for treating and preventing staphylococcus aureus infections
JP2025063187A5 (cg-RX-API-DMAC7.html)
AU2008332943B9 (en) G immunoglobulin used against anthrax toxins
JP2023552846A5 (cg-RX-API-DMAC7.html)
KR20250090469A (ko) 니파바이러스에 특이적인 단클론 항체 및 이의 용도
HK40065443A (en) Compositions and methods for treating and preventing staphylococcus aureus infections
JPWO2023153471A5 (cg-RX-API-DMAC7.html)
JP2025501452A5 (cg-RX-API-DMAC7.html)
JP2023544614A5 (cg-RX-API-DMAC7.html)
TH1801001277A (th) แอนติบอดีที่ล้างฤทธิ์ไวรัสตับอักเสบ b ได้อย่างมีศักยภาพและการใช้ของสิ่งนั้น